Clinical Trial Update: A Study on Predictive Value of ERCC1 in Esophageal Cancer Patients Treated With Paclitaxel and Cisplatin [Phase 2]

View source ↗

Summary

This entry describes a Phase 2 clinical trial evaluating whether ERCC1 can predict outcomes in Esophageal cancer patients treated with paclitaxel and cisplatin.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Esophageal Cancer | Phase 2 | Status: UNKNOWN